Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment

Cancer immunotherapies that remove checkpoint restraints on adaptive immunity are gaining clinical momentum. Approaches aimed at intrinsic cellular immunity in the tumor microenvironment are less understood, but are of intense interest, based on their ability to induce tumor cell apoptosis while orc...

Descripción completa

Detalles Bibliográficos
Autores principales: Elion, David L., Cook, Rebecca S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034747/
https://www.ncbi.nlm.nih.gov/pubmed/29989043
http://dx.doi.org/10.18632/oncotarget.25626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034747/
https://www.ncbi.nlm.nih.gov/pubmed/29989043
http://dx.doi.org/10.18632/oncotarget.25626

Ejemplares similares